Myoclonus-Dystonia Presentation of ATM Gene Mutation in a Canadian Mennonite

Jacky Ganguly; Mellany Tuesta Bernaola; Sharan Goobie; Asuri Prasad; Mandar Jog

doi:10.1002/mdc3.13369

Myoclonus-Dystonia Presentation of ATM Gene Mutation in a Canadian Mennonite

Jacky Ganguly, Mellany Tuesta Bernaola, Sharan Goobie, Asuri Prasad, Mandar Jog

Medicine

Producción científica: Contribución a una revista › Comentario/debate › revisión exhaustiva

5 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	264-267
Número de páginas	4
Publicación	Movement Disorders Clinical Practice
Volumen	9
N.º	2
DOI	https://doi.org/10.1002/mdc3.13369
Estado	Published - feb. 2022

Nota bibliográfica

Funding Information:
M.J. receives speaker's fees and research funding from Allergan, AbbVie, Merz Pharmaceuticals, Boston Scientific, Valeo Pharma, Sunovion, and Paladin Labs. M.J. also receives grants from Parkinson society Canada, Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council of Canada (NSERC), Mathematics of Information Technology and Complex Systems (MITACS), Research Council of Norway, Parkinson Society of Southwestern Ontario, Dystonia Medical Research Foundation and Academic Medical Organization of Southwestern Ontario. J.G. receives fellowship funding from the Academic Medical Organization of Southwestern Ontario (AMOSO). M.T.B. receives fellowship funding from the Parkinson Society of Southwestern Ontario (PSSO). A.P. and S.G. do not declare any conflict of interest.

ASJC Scopus Subject Areas

Neurology
Clinical Neurology

PubMed: MeSH publication types

Journal Article

Acceder al documento

10.1002/mdc3.13369

Otros archivos y enlaces

Citar esto

@article{add8de0c05cd49dab5d1c220f2596dba,

title = "Myoclonus-Dystonia Presentation of ATM Gene Mutation in a Canadian Mennonite",

author = "Jacky Ganguly and Bernaola, {Mellany Tuesta} and Sharan Goobie and Asuri Prasad and Mandar Jog",

note = "Funding Information: M.J. receives speaker's fees and research funding from Allergan, AbbVie, Merz Pharmaceuticals, Boston Scientific, Valeo Pharma, Sunovion, and Paladin Labs. M.J. also receives grants from Parkinson society Canada, Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council of Canada (NSERC), Mathematics of Information Technology and Complex Systems (MITACS), Research Council of Norway, Parkinson Society of Southwestern Ontario, Dystonia Medical Research Foundation and Academic Medical Organization of Southwestern Ontario. J.G. receives fellowship funding from the Academic Medical Organization of Southwestern Ontario (AMOSO). M.T.B. receives fellowship funding from the Parkinson Society of Southwestern Ontario (PSSO). A.P. and S.G. do not declare any conflict of interest.",

year = "2022",

month = feb,

doi = "10.1002/mdc3.13369",

language = "English",

volume = "9",

pages = "264--267",

journal = "Movement Disorders Clinical Practice",

issn = "2330-1619",

publisher = "John Wiley and Sons Ltd",

number = "2",

}

TY - JOUR

T1 - Myoclonus-Dystonia Presentation of ATM Gene Mutation in a Canadian Mennonite

AU - Ganguly, Jacky

AU - Bernaola, Mellany Tuesta

AU - Goobie, Sharan

AU - Prasad, Asuri

AU - Jog, Mandar

N1 - Funding Information: M.J. receives speaker's fees and research funding from Allergan, AbbVie, Merz Pharmaceuticals, Boston Scientific, Valeo Pharma, Sunovion, and Paladin Labs. M.J. also receives grants from Parkinson society Canada, Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council of Canada (NSERC), Mathematics of Information Technology and Complex Systems (MITACS), Research Council of Norway, Parkinson Society of Southwestern Ontario, Dystonia Medical Research Foundation and Academic Medical Organization of Southwestern Ontario. J.G. receives fellowship funding from the Academic Medical Organization of Southwestern Ontario (AMOSO). M.T.B. receives fellowship funding from the Parkinson Society of Southwestern Ontario (PSSO). A.P. and S.G. do not declare any conflict of interest.

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85120488743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120488743&partnerID=8YFLogxK

U2 - 10.1002/mdc3.13369

DO - 10.1002/mdc3.13369

M3 - Comment/debate

C2 - 35146067

AN - SCOPUS:85120488743

SN - 2330-1619

VL - 9

SP - 264

EP - 267

JO - Movement Disorders Clinical Practice

JF - Movement Disorders Clinical Practice

IS - 2

ER -